EBV
Clinical trials for EBV explained in plain language.
Never miss a new study
Get alerted when new EBV trials appear
Sign up with your email to follow new studies for EBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New EBV vaccine trial aims to prevent mono and related cancers
⭐️ VACCINE ⭐️ Recruiting nowThis study tests the safety of two experimental vaccines designed to prevent Epstein-Barr virus (EBV) infection, which causes mono and is linked to certain cancers and autoimmune diseases. Healthy adults aged 18 to 29, whether or not they have had EBV before, will receive three d…
Matched conditions: EBV
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:01 UTC
-
New drug combo aims to tame Epstein-Barr virus in chronic disease
Disease control Recruiting nowThis study tests whether combining two drugs, golidocitinib and selinexor, can control chronic active Epstein-Barr virus disease (CAEBVD). About 28 adults with active symptoms will receive the treatment. The goal is to reduce virus levels and improve disease activity.
Matched conditions: EBV
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Why do some people suffer severe viral infections? scientists investigate immune defects
Knowledge-focused Recruiting nowThis study looks at people who have had unusually severe or long-lasting viral infections, like serious cases of herpes, HPV, or CMV. Researchers want to find out if problems in the immune system or genes are to blame. Up to 600 participants and their relatives will provide blood…
Matched conditions: EBV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 26, 2026 08:18 UTC